Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer
NCT01581749
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Prostate Neoplasms
Interventions
RADIATION:
"TrueBeam" stereotactic body radiosurgery
Sponsor
Albert DeNittis